Search Results - "Daniel, GW"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Cardiac output monitoring in children: a review by Cave, Daniel GW, Bautista, Melissa J, Mustafa, Khurram, Bentham, James R

    Published in Archives of disease in childhood (01-12-2023)
    “…Cardiac output monitoring enables physiology-directed management of critically ill children and aids in the early detection of clinical deterioration. Multiple…”
    Get full text
    Journal Article
  5. 5

    Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction? by Johnston, Daniel G.W., Kirby, Brian, Tobin, Desmond J.

    Published in Experimental dermatology (01-10-2021)
    “…The innate immune system of human skin consists of a multi‐layered barrier consisting of cells and soluble effector molecules charged with maintaining…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia by Downer, Eric J., Johnston, Daniel G.W., Lynch, Marina A.

    Published in Molecular and cellular neuroscience (01-09-2013)
    “…Accumulating evidence continues to underpin the role of the innate immune system in pathologies associated with neuroinflammation. Innate immunity is regulated…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Improving the tools of clinical pharmacology: Goals for 2017 and beyond by Zineh, I, Abernethy, D, Hop, CECA, Bello, A, McClellan, MB, Daniel, GW, Romine, MH

    Published in Clinical pharmacology and therapeutics (01-01-2017)
    “…Current trends in pronounced late‐stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders…”
    Get full text
    Journal Article
  11. 11
  12. 12

    MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice by Aviello, Gabriella, Corr, Sinéad C, Johnston, Daniel G W, O'Neill, Luke A J, Fallon, Padraic G

    “…Toll-like receptors (TLRs) play a central role in the recognition and response to microbial pathogens and in the maintenance and function of the epithelial…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Improving evidence developed from population-level experience with targeted agents by McClellan, MB, Daniel, GW, Dickson, D, Perlmutter, J, Berger, DP, Miller, V, Nussbaum, S, Malin, J, Romine, MH, Schilsky, RL

    Published in Clinical pharmacology and therapeutics (01-05-2015)
    “…Off‐label drug use is common in oncology, due in part to significant unmet medical need, the rarity of many cancers, and the difficulty of conducting…”
    Get full text
    Journal Article
  15. 15
  16. 16

    P2-17-06: Patterns of Bone Density Evaluation in a Community Population Treated with Aromatase Inhibitors by Ligibel, JA, O'Malley, AJ, Fisher, M, Daniel, GW, Winer, EP, Keating, NL

    Published in Cancer research (Chicago, Ill.) (15-12-2011)
    “…Aromatase inhibitors (AIs) lead to an increased risk of bone loss and fracture. Fracture rates in adjuvant AI studies have ranged from 2.3% to 11%, with higher…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20